6Minucci S, Nervi C, Lo Coco F, et al. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? [J ]. Oncogene, 2001,20(24) : 3110- 3115.
7Weidle U H, Grossmann A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment [J]. Anticancer Res, 2000,20(3A) : 1471-1485.
8Takai N, Desmond J C, Kumagai T, et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells [J]. Clin Cancer Res, 2004, 10(3): 1141-1149.
9Li X N, Shu Q, Su J M, et al. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC [J]. Mol Cancer Ther, 2005,4 (12) : 1912-1922.
10Gurvich N, Tsygankova O M, Meinkoth J L, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation [J]. Cancer Res, 2004,64(3) : 1079-1086.
